John A Orwin - Net Worth and Insider Trading
John A Orwin Net Worth
The estimated net worth of John A Orwin is at least $4 Million dollars as of 2024-12-28. John A Orwin is the Director of Seagen Inc and owns about 10,700 shares of Seagen Inc (SGEN) stock worth over $2 Million. John A Orwin is the President & CEO of Relypsa Inc and owns about 54,375 shares of Relypsa Inc (RLYP) stock worth over $2 Million. John A Orwin is also the PRESIDENT & CEO of Atreca Inc and owns about 77,541 shares of Atreca Inc (BCEL) stock worth over $6,979. Details can be seen in John A Orwin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John A Orwin has not made any transactions after 2023-09-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John A Orwin
John A Orwin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John A Orwin owns 7 companies in total, including Seagen Inc (SGEN) , Travere Therapeutics Inc (TVTX) , and Atreca Inc (BCEL) among others .
Click here to see the complete history of John A Orwin’s form 4 insider trades.
Insider Ownership Summary of John A Orwin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGEN | Seagen Inc | 2019-05-20 | director |
| TVTX | Travere Therapeutics Inc | 2017-03-23 | director |
| BCEL | Atreca Inc | 2023-09-01 | director & President & CEO |
 | | 2016-09-01 | director & President & CEO |
| | 2013-06-27 | director |
| | 2012-06-07 | director |
| | 2023-09-15 | director |
John A Orwin Latest Holdings Summary
John A Orwin currently owns a total of 3 stocks. Among these stocks, John A Orwin owns 10,700 shares of Seagen Inc (SGEN) as of February 12, 2016, with a value of $2 Million and a weighting of 58.36%. John A Orwin owns 54,375 shares of Relypsa Inc (RLYP) as of December 7, 2015, with a value of $2 Million and a weighting of 41.48%. John A Orwin also owns 77,541 shares of Atreca Inc (BCEL) as of September 1, 2023, with a value of $6,979 and a weighting of 0.17%.
Latest Holdings of John A Orwin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGEN | Seagen Inc | 2016-02-12 | 10,700 | 228.74 | 2,447,518 |
| RLYP | Relypsa Inc | 2015-12-07 | 54,375 | 31.99 | 1,739,456 |
| BCEL | Atreca Inc | 2023-09-01 | 77,541 | 0.09 | 6,979 |
Holding Weightings of John A Orwin
John A Orwin Form 4 Trading Tracker
According to the SEC Form 4 filings, John A Orwin has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the acquisition of 2,000 shares on February 12, 2016, which cost John A Orwin around $56,660.
According to the SEC Form 4 filings, John A Orwin has made a total of 0 transactions in Relypsa Inc (RLYP) over the past 5 years. The most-recent trade in Relypsa Inc is the sale of 15,000 shares on December 7, 2015, which brought John A Orwin around $424,200.
According to the SEC Form 4 filings, John A Orwin has made a total of 3 transactions in Atreca Inc (BCEL) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Atreca Inc is the sale of 22,951 shares on September 1, 2023, which brought John A Orwin around $8,492.
Insider Trading History of John A Orwin
- 1
John A Orwin Trading Performance
GuruFocus tracks the stock performance after each of John A Orwin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John A Orwin is 98.3%. GuruFocus also compares John A Orwin's trading performance to market benchmark return within the same time period. The performance of stocks bought by John A Orwin within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John A Orwin's insider trading performs compared to the benchmark.
Performance of John A Orwin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 50.55 | | | | | |
| Relative Return to S&P 500(%) | 42.49 | | | | | |
John A Orwin Ownership Network
John A Orwin Owned Company Details
What does Seagen Inc do?
Who are the key executives at Seagen Inc?
John A Orwin is the director of Seagen Inc. Other key executives at Seagen Inc include director & Chief Executive Officer David R Epstein , See Remarks Vaughn B Himes , and EVP & Commercial Charles R Romp .
Seagen Inc (SGEN) Insider Trades Summary
Over the past 18 months, John A Orwin made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 19,816 shares made by Vaughn B Himes , a net sale of 1,746 shares made by Charles R Romp , and a net sale of 5,116 shares made by Roger D Dansey .
In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 47,272 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 47,272 shares.
Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seagen Inc Insider Transactions
John A Orwin Mailing Address
Above is the net worth, insider trading, and ownership report for John A Orwin. You might contact John A Orwin via mailing address: C/o Relypsa, Inc., 700 Saginaw Dr., Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
